Department of Obstetrics and Gynecology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
Department of Obstetrics and Gynecology, NTT Medical Center Tokyo, 5-9-22 Higashi-Gotanda, Shinagawa-ku, Tokyo, 141-8625, Japan.
Int J Clin Oncol. 2018 Jun;23(3):514-521. doi: 10.1007/s10147-017-1222-y. Epub 2017 Dec 13.
The diagnostic performances of the International Ovarian Tumor Analysis (IOTA) ultrasound-based logistic regression model (LR2) and magnetic resonance imaging (MRI) in discriminating between benign and malignant adnexal masses have not been directly compared in a single study.
Using the IOTA LR2 model and subjective interpretation of MRI findings by experienced radiologists, 265 consecutive patients with adnexal masses were preoperatively evaluated in two hospitals between February 2014 and December 2015. Definitive histological diagnosis of excised tissues was used as a gold standard.
From the 265 study subjects, 54 (20.4%) tumors were histologically diagnosed as malignant (including 11 borderline and 3 metastatic tumors). Preoperative diagnoses of malignant tumors showed 91.7% total agreement between IOTA LR2 and MRI, with a kappa value of 0.77 [95% confidence interval (CI), 0.68-0.86]. Sensitivity of IOTA LR2 (0.94, 95% CI, 0.85-0.98) for predicting malignant tumors was similar to that of MRI (0.96, 95% CI, 0.87-0.99; P = 0.99), whereas specificity of IOTA LR2 (0.98, 95% CI, 0.95-0.99) was significantly higher than that of MRI (0.91, 95% CI, 0.87-0.95; P = 0.002). Combined IOTA LR2 and MRI results gave the greatest sensitivity (1.00, 95% CI, 0.93-1.00) and had similar specificity (0.91, 95% CI, 0.86-0.94) to MRI.
The IOTA LR2 model had a similar sensitivity to MRI for discriminating between benign and malignant tumors and a higher specificity compared with MRI. Our findings suggest that the IOTA LR2 model, either alone or in conjunction with MRI, should be included in preoperative evaluation of adnexal masses.
国际卵巢肿瘤分析(IOTA)基于超声的逻辑回归模型(LR2)和磁共振成像(MRI)在鉴别良恶性附件肿块方面的诊断性能尚未在单一研究中直接比较。
使用 IOTA LR2 模型和经验丰富的放射科医生对 MRI 结果的主观解读,对 2014 年 2 月至 2015 年 12 月期间在两家医院就诊的 265 例附件肿块患者进行了术前评估。切除组织的明确组织学诊断被用作金标准。
在 265 例研究对象中,54 例(20.4%)肿瘤的组织学诊断为恶性(包括 11 例交界性和 3 例转移性肿瘤)。IOTA LR2 和 MRI 对恶性肿瘤的术前诊断结果完全一致,kappa 值为 0.77(95%置信区间[CI],0.68-0.86)。IOTA LR2(0.94,95%CI,0.85-0.98)预测恶性肿瘤的敏感性与 MRI(0.96,95%CI,0.87-0.99;P=0.99)相似,而 IOTA LR2 的特异性(0.98,95%CI,0.95-0.99)明显高于 MRI(0.91,95%CI,0.87-0.95;P=0.002)。IOTA LR2 和 MRI 联合结果具有最高的敏感性(1.00,95%CI,0.93-1.00),特异性与 MRI 相似(0.91,95%CI,0.86-0.94)。
IOTA LR2 模型在鉴别良恶性肿瘤方面与 MRI 的敏感性相似,特异性高于 MRI。我们的研究结果表明,IOTA LR2 模型无论是单独使用还是与 MRI 联合使用,都应纳入附件肿块的术前评估。